UK QPPVs Fear Brexit Could Seriously Threaten Their Role In Pharmacovigilance
Executive Summary
UK based QPPVs are worried about the direct and tangible impact of Brexit on their current jobs, fearing that the QPPV role may either completely vanish from the UK or have its authority undermined.
You may also be interested in...
UK QPPVs Brace For Uncertain Prospects Post Brexit
UK-based qualified persons responsible for pharmacovigilance face an uncertain future following Brexit, as the law requires them to “operate and reside” in the EU. They are calling for an appropriate transition period until industry makes alternate arrangements.
UK Industry Pleased With Brexit Committee's Focus On Regulation
Industry group ABPI is focusing on the fact that the report from parliamentarians on the cross-party Exiting the EU Committee has made at least some mention of the need to ensure that medicines regulation is ready for Brexit on “day one.”
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.